巨噬细胞移动抑制因子
基因型
等位基因
内科学
急性冠脉综合征
医学
胃肠病学
多态性(计算机科学)
等位基因频率
免疫学
病例对照研究
逻辑回归
人口
基因
生物
遗传学
心肌梗塞
细胞因子
环境卫生
作者
Guoli Du,Jun‐Yi Luo,Duolao Wang,Yanhong Li,Binbin Fang,Xiao‐Mei Li,Xiao‐Ming Gao,Yi‐Ning Yang
标识
DOI:10.1038/s41598-019-56949-z
摘要
Abstract Macrophage migration inhibitory factor (MIF) has been recognized as a major player in the pathogenesis of atherosclerosis. This study determined the association between polymorphisms of MIF gene and acute coronary syndrome (ACS). The polymorphism of MIF gene (rs755622, rs1007888 and rs2096525) was analyzed in 1153 healthy controls and 699 ACS cases in Chinese Han population. Plasma MIF level was also measured in part of ACS patients (139/19.9%) and healthy controls (129/11.2%) randomly. Most participants including healthy controls and ACS patients carried rs755622 GG (63.1% vs. 56.7%) and CG genotypes (33.1% vs. 38.9%) and G allele of rs755622 (79.6% vs. 76.1%, respectively), while CC genotype (3.8% vs. 4.4%) and C allele (20.4% vs. 23.9%) carriers were the lowest. Multivariate logistic regression analysis showed that carriers with rs755622 C allele had a higher risk of ACS compared to other genotypes (AOR = 1.278, 95% CI: 1.042–1.567). In addition, CC genotype carriers had the highest plasma levels of MIF than other genotype carriers. The MIF level in ACS patients with CC genotype was significantly higher than ACS patients carrying GG genotype and healthy controls carrying 3 different genotypes of MIF gene rs755622. Our findings indicate that MIF gene rs755622 variant C allele is associated with increased risk of ACS. Identification of this MIF gene polymorphism may help for predicting the risk of ACS.
科研通智能强力驱动
Strongly Powered by AbleSci AI